[Pregnancy after cancer: for whom and when?].
Planning a pregnancy for patients with a history of cancer, including breast cancer, is a clinical situation that becomes more and more common. Several specific items are to be discussed: decrease of fertility after cancer treatment, fertility preservation options, impact of pregnancy on cancer recurrence risk and appropriate interval between cancer and pregnancy. Programming pregnancy after cancer is doable in a multidisciplinary setting, and begins at cancer diagnosis to anticipate the various specific pitfalls. Favor adequate oncologic care remains the leading rule.
AP-HP, hôpital Bichat, département de gynécologie obstétrique médecine de la reproduction, 75018 Paris, France.
Anne Laure
AL
Margulies
AP-HP, université Pierre-et-Marie-Curie Paris 6, hôpital Tenon, département de gynécologie obstétrique médecine de la reproduction, 75020 Paris, France; Réseau INCA cancers associés à La grossesse (CALG), 75020 Paris, France.
Lise
L
Selleret
AP-HP, université Pierre-et-Marie-Curie Paris 6, hôpital Tenon, département de gynécologie obstétrique médecine de la reproduction, 75020 Paris, France; Réseau INCA cancers associés à La grossesse (CALG), 75020 Paris, France.
Sonia
S
Zilberman
Hôpital Tenon, service de radiologie, 75020 Paris, France.
Isabelle Thomassin
IT
Nagarra
Hôpital Tenon, service de radiologie, 75020 Paris, France.
Jocelyne
J
Chopier
Hôpital Tenon, service d'oncologie médicale, 75020 Paris, France.
Joseph
J
Gligorov
Réseau INCA cancers associés à La grossesse (CALG), 75020 Paris, France; AP-HP, hôpital Trousseau, département de gynécologie obstétrique, 75012 Paris, France.
Paul
P
Berveiller
AP-HP, université Pierre-et-Marie-Curie Paris 6, hôpital Tenon, département de gynécologie obstétrique médecine de la reproduction, 75020 Paris, France; Réseau INCA cancers associés à La grossesse (CALG), 75020 Paris, France; Université Pierre-et-Marie-Curie Paris 6, UMRS-938, 75005 Paris, France.
Marcos
M
Ballester
AP-HP, université Pierre-et-Marie-Curie Paris 6, hôpital Tenon, département de gynécologie obstétrique médecine de la reproduction, 75020 Paris, France; Réseau INCA cancers associés à La grossesse (CALG), 75020 Paris, France; Université Pierre-et-Marie-Curie Paris 6, UMRS-938, 75005 Paris, France.
Emile
E
Darai
AP-HP, université Pierre-et-Marie-Curie Paris 6, hôpital Tenon, département de gynécologie obstétrique médecine de la reproduction, 75020 Paris, France; Réseau INCA cancers associés à La grossesse (CALG), 75020 Paris, France; Université Pierre-et-Marie-Curie Paris 6, UMRS-938, 75005 Paris, France. Electronic address: nathalie.chabbert-buffet@tnn.aphp.fr.
Nathalie
N
Chabbert-Buffet
D000328:Adult; D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001942:Breast Feeding; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000523:psychology; D015925:Cryopreservation; D005260:Female; D059247:Fertility Preservation; D005306:Fertilization; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000523:psychology / Q000628:therapy*; D065851:Ovarian Reserve / Q000502:physiology; D011247:Pregnancy; D011379:Prognosis
D000970:Antineoplastic Agents
Cancer; Chemotherapy; Chimiothérapie; Fertility; Fertilité; Grossesse; Onco-fertility; Onco-fertilité; Pregnancy